Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes

Detalhes bibliográficos
Autor(a) principal: Brás, Susana Maria Pereira
Data de Publicação: 2020
Outros Autores: França, Ângela Maria Oliveira Sousa, Cerca, Nuno
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/65740
Resumo: Human blood is often used as an ex vivo model to mimic the environment encountered by pathogens inside the host. A significant variety of experimental conditions has been reported. However, optimization strategies are often not described. This study aimed to evaluate key parameters that are expected to influence Staphylococcus epidermidis gene expression when using human blood ex vivo models. Our data confirmed that blood antimicrobial activity was dependent on initial bacterial concentration. Furthermore, blood degradation over time resulted in lower antimicrobial activity, with a 2% loss of leukocytes viability correlating with a 5-fold loss of antimicrobial activity against S. epidermidis. We further demonstrated that the volume of human blood could be reduced to as little as 0.18 mL without affecting the stability of gene expression of the tested genes. Overall, the data described herein highlight experimental parameters that should be considered when using a human blood ex vivo model for S. epidermidis gene expression analysis.
id RCAP_fa62b1a8dca9583142958d21e6482959
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/65740
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genesBacterial survivalStaphylococcus epidermidisHuman blood ex vivo modelVolume of human bloodGene expressionScience & TechnologyHuman blood is often used as an ex vivo model to mimic the environment encountered by pathogens inside the host. A significant variety of experimental conditions has been reported. However, optimization strategies are often not described. This study aimed to evaluate key parameters that are expected to influence Staphylococcus epidermidis gene expression when using human blood ex vivo models. Our data confirmed that blood antimicrobial activity was dependent on initial bacterial concentration. Furthermore, blood degradation over time resulted in lower antimicrobial activity, with a 2% loss of leukocytes viability correlating with a 5-fold loss of antimicrobial activity against S. epidermidis. We further demonstrated that the volume of human blood could be reduced to as little as 0.18 mL without affecting the stability of gene expression of the tested genes. Overall, the data described herein highlight experimental parameters that should be considered when using a human blood ex vivo model for S. epidermidis gene expression analysis.This work was supported by the Portuguese Foundation for Science and Technology (FCT) by the funded project PTDC/BIA-MOL/29553/2017, under the scope of COMPETE2020 [POCI-01-0145-FEDER-02955 and by the strategic funding of unit UIDB/04469/2020 and by European funds under BioTecNorte operation [NORTE-01-0145-FEDER-000004 funded by European Regional Development Fund under the scope of Norte2020. Susana Brás is supported by a fellowship granted by a Doctoral Advanced Training [Norte 69- 2015-15 funded by the European Social Fund under the scope of Norte2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptinfo:eu-repo/semantics/publishedVersionPeerj, Inc.Universidade do MinhoBrás, Susana Maria PereiraFrança, Ângela Maria Oliveira SousaCerca, Nuno2020-06-152020-06-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/65740engBrás, Susana; França, Angela; Cerca, Nuno, Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes. PeerJ, 8(e9295), 20202167-835910.7717/peerj.9295https://peerj.com/info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:34:08Zoai:repositorium.sdum.uminho.pt:1822/65740Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:29:45.956593Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
title Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
spellingShingle Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
Brás, Susana Maria Pereira
Bacterial survival
Staphylococcus epidermidis
Human blood ex vivo model
Volume of human blood
Gene expression
Science & Technology
title_short Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
title_full Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
title_fullStr Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
title_full_unstemmed Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
title_sort Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes
author Brás, Susana Maria Pereira
author_facet Brás, Susana Maria Pereira
França, Ângela Maria Oliveira Sousa
Cerca, Nuno
author_role author
author2 França, Ângela Maria Oliveira Sousa
Cerca, Nuno
author2_role author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Brás, Susana Maria Pereira
França, Ângela Maria Oliveira Sousa
Cerca, Nuno
dc.subject.por.fl_str_mv Bacterial survival
Staphylococcus epidermidis
Human blood ex vivo model
Volume of human blood
Gene expression
Science & Technology
topic Bacterial survival
Staphylococcus epidermidis
Human blood ex vivo model
Volume of human blood
Gene expression
Science & Technology
description Human blood is often used as an ex vivo model to mimic the environment encountered by pathogens inside the host. A significant variety of experimental conditions has been reported. However, optimization strategies are often not described. This study aimed to evaluate key parameters that are expected to influence Staphylococcus epidermidis gene expression when using human blood ex vivo models. Our data confirmed that blood antimicrobial activity was dependent on initial bacterial concentration. Furthermore, blood degradation over time resulted in lower antimicrobial activity, with a 2% loss of leukocytes viability correlating with a 5-fold loss of antimicrobial activity against S. epidermidis. We further demonstrated that the volume of human blood could be reduced to as little as 0.18 mL without affecting the stability of gene expression of the tested genes. Overall, the data described herein highlight experimental parameters that should be considered when using a human blood ex vivo model for S. epidermidis gene expression analysis.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-15
2020-06-15T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/65740
url http://hdl.handle.net/1822/65740
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brás, Susana; França, Angela; Cerca, Nuno, Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes. PeerJ, 8(e9295), 2020
2167-8359
10.7717/peerj.9295
https://peerj.com/
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Peerj, Inc.
publisher.none.fl_str_mv Peerj, Inc.
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132798993301504